Investigating the Endo-Lysosomal System in Major Neurocognitive Disorders Due to Alzheimer’s Disease, Frontotemporal Lobar Degeneration and Lewy Body Disease: Evidence for SORL1 as a Cross-Disease Gene

Dysfunctions in the endo-lysosomal system have been hypothesized to underlie neurodegeneration in major neurocognitive disorders due to Alzheimer’s disease (AD), Frontotemporal Lobar Degeneration (FTLD), and Lewy body disease (DLB). The aim of this study is to investigate whether these diseases shar...

Full description

Bibliographic Details
Main Authors: Luisa Benussi, Antonio Longobardi, Cemile Kocoglu, Matteo Carrara, Sonia Bellini, Clarissa Ferrari, Roland Nicsanu, Claudia Saraceno, Cristian Bonvicini, Silvia Fostinelli, Roberta Zanardini, Marcella Catania, Matthieu Moisse, Philip Van Damme, Giuseppe Di Fede, Giuliano Binetti, Christine Van Broeckhoven, Julie van der Zee, Roberta Ghidoni
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:International Journal of Molecular Sciences
Subjects:
Online Access:https://www.mdpi.com/1422-0067/22/24/13633
_version_ 1797503754590748672
author Luisa Benussi
Antonio Longobardi
Cemile Kocoglu
Matteo Carrara
Sonia Bellini
Clarissa Ferrari
Roland Nicsanu
Claudia Saraceno
Cristian Bonvicini
Silvia Fostinelli
Roberta Zanardini
Marcella Catania
Matthieu Moisse
Philip Van Damme
Giuseppe Di Fede
Giuliano Binetti
Christine Van Broeckhoven
Julie van der Zee
Roberta Ghidoni
author_facet Luisa Benussi
Antonio Longobardi
Cemile Kocoglu
Matteo Carrara
Sonia Bellini
Clarissa Ferrari
Roland Nicsanu
Claudia Saraceno
Cristian Bonvicini
Silvia Fostinelli
Roberta Zanardini
Marcella Catania
Matthieu Moisse
Philip Van Damme
Giuseppe Di Fede
Giuliano Binetti
Christine Van Broeckhoven
Julie van der Zee
Roberta Ghidoni
author_sort Luisa Benussi
collection DOAJ
description Dysfunctions in the endo-lysosomal system have been hypothesized to underlie neurodegeneration in major neurocognitive disorders due to Alzheimer’s disease (AD), Frontotemporal Lobar Degeneration (FTLD), and Lewy body disease (DLB). The aim of this study is to investigate whether these diseases share genetic variability in the endo-lysosomal pathway. In AD, DLB, and FTLD patients and in controls (948 subjects), we performed a targeted sequencing of the top 50 genes belonging to the endo-lysosomal pathway. Genetic analyses revealed (i) four previously reported disease-associated variants in the SORL1 (p.N1246K, p.N371T, p.D2065V) and DNAJC6 genes (p.M133L) in AD, FTLD, and DLB, extending the previous knowledge attesting SORL1 and DNAJC6 as AD- and PD-related genes, respectively; (ii) three predicted null variants in AD patients in the SORL1 (p.R985X in early onset familial AD, p.R1207X) and PPT1 (p.R48X in early onset familial AD) genes, where loss of function is a known disease mechanism. A single variant and gene burden analysis revealed some nominally significant results of potential interest for SORL1 and DNAJC6 genes. Our data highlight that genes controlling key endo-lysosomal processes (i.e., protein sorting/transport, clathrin-coated vesicle uncoating, lysosomal enzymatic activity regulation) might be involved in AD, FTLD and DLB pathogenesis, thus suggesting an etiological link behind these diseases.
first_indexed 2024-03-10T03:54:51Z
format Article
id doaj.art-a4308e122d324471877fb0d8ce6d7d02
institution Directory Open Access Journal
issn 1661-6596
1422-0067
language English
last_indexed 2024-03-10T03:54:51Z
publishDate 2021-12-01
publisher MDPI AG
record_format Article
series International Journal of Molecular Sciences
spelling doaj.art-a4308e122d324471877fb0d8ce6d7d022023-11-23T08:49:15ZengMDPI AGInternational Journal of Molecular Sciences1661-65961422-00672021-12-0122241363310.3390/ijms222413633Investigating the Endo-Lysosomal System in Major Neurocognitive Disorders Due to Alzheimer’s Disease, Frontotemporal Lobar Degeneration and Lewy Body Disease: Evidence for SORL1 as a Cross-Disease GeneLuisa Benussi0Antonio Longobardi1Cemile Kocoglu2Matteo Carrara3Sonia Bellini4Clarissa Ferrari5Roland Nicsanu6Claudia Saraceno7Cristian Bonvicini8Silvia Fostinelli9Roberta Zanardini10Marcella Catania11Matthieu Moisse12Philip Van Damme13Giuseppe Di Fede14Giuliano Binetti15Christine Van Broeckhoven16Julie van der Zee17Roberta Ghidoni18Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, I-25125 Brescia, ItalyMolecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, I-25125 Brescia, ItalyNeurodegenerative Brain Diseases, VIB Center for Molecular Neurology, VIB, B-2610 Antwerp, BelgiumService of Statistics, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, I-25125 Brescia, ItalyMolecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, I-25125 Brescia, ItalyService of Statistics, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, I-25125 Brescia, ItalyMolecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, I-25125 Brescia, ItalyMolecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, I-25125 Brescia, ItalyMolecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, I-25125 Brescia, ItalyMAC-Memory Clinic and Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, I-25125 Brescia, ItalyMolecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, I-25125 Brescia, ItalyNeurology 5/Neuropathology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, I-20133 Milan, ItalyDepartment of Neurosciences and Leuven Brain Institute (LBI), KU Leuven-University of Leuven, B-3000 Leuven, BelgiumDepartment of Neurosciences and Leuven Brain Institute (LBI), KU Leuven-University of Leuven, B-3000 Leuven, BelgiumNeurology 5/Neuropathology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, I-20133 Milan, ItalyMAC-Memory Clinic and Molecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, I-25125 Brescia, ItalyNeurodegenerative Brain Diseases, VIB Center for Molecular Neurology, VIB, B-2610 Antwerp, BelgiumNeurodegenerative Brain Diseases, VIB Center for Molecular Neurology, VIB, B-2610 Antwerp, BelgiumMolecular Markers Laboratory, IRCCS Istituto Centro San Giovanni di Dio Fatebenefratelli, I-25125 Brescia, ItalyDysfunctions in the endo-lysosomal system have been hypothesized to underlie neurodegeneration in major neurocognitive disorders due to Alzheimer’s disease (AD), Frontotemporal Lobar Degeneration (FTLD), and Lewy body disease (DLB). The aim of this study is to investigate whether these diseases share genetic variability in the endo-lysosomal pathway. In AD, DLB, and FTLD patients and in controls (948 subjects), we performed a targeted sequencing of the top 50 genes belonging to the endo-lysosomal pathway. Genetic analyses revealed (i) four previously reported disease-associated variants in the SORL1 (p.N1246K, p.N371T, p.D2065V) and DNAJC6 genes (p.M133L) in AD, FTLD, and DLB, extending the previous knowledge attesting SORL1 and DNAJC6 as AD- and PD-related genes, respectively; (ii) three predicted null variants in AD patients in the SORL1 (p.R985X in early onset familial AD, p.R1207X) and PPT1 (p.R48X in early onset familial AD) genes, where loss of function is a known disease mechanism. A single variant and gene burden analysis revealed some nominally significant results of potential interest for SORL1 and DNAJC6 genes. Our data highlight that genes controlling key endo-lysosomal processes (i.e., protein sorting/transport, clathrin-coated vesicle uncoating, lysosomal enzymatic activity regulation) might be involved in AD, FTLD and DLB pathogenesis, thus suggesting an etiological link behind these diseases.https://www.mdpi.com/1422-0067/22/24/13633SORL1DNAJC6PPT1endo-lysosomal genesNGScross-disease
spellingShingle Luisa Benussi
Antonio Longobardi
Cemile Kocoglu
Matteo Carrara
Sonia Bellini
Clarissa Ferrari
Roland Nicsanu
Claudia Saraceno
Cristian Bonvicini
Silvia Fostinelli
Roberta Zanardini
Marcella Catania
Matthieu Moisse
Philip Van Damme
Giuseppe Di Fede
Giuliano Binetti
Christine Van Broeckhoven
Julie van der Zee
Roberta Ghidoni
Investigating the Endo-Lysosomal System in Major Neurocognitive Disorders Due to Alzheimer’s Disease, Frontotemporal Lobar Degeneration and Lewy Body Disease: Evidence for SORL1 as a Cross-Disease Gene
International Journal of Molecular Sciences
SORL1
DNAJC6
PPT1
endo-lysosomal genes
NGS
cross-disease
title Investigating the Endo-Lysosomal System in Major Neurocognitive Disorders Due to Alzheimer’s Disease, Frontotemporal Lobar Degeneration and Lewy Body Disease: Evidence for SORL1 as a Cross-Disease Gene
title_full Investigating the Endo-Lysosomal System in Major Neurocognitive Disorders Due to Alzheimer’s Disease, Frontotemporal Lobar Degeneration and Lewy Body Disease: Evidence for SORL1 as a Cross-Disease Gene
title_fullStr Investigating the Endo-Lysosomal System in Major Neurocognitive Disorders Due to Alzheimer’s Disease, Frontotemporal Lobar Degeneration and Lewy Body Disease: Evidence for SORL1 as a Cross-Disease Gene
title_full_unstemmed Investigating the Endo-Lysosomal System in Major Neurocognitive Disorders Due to Alzheimer’s Disease, Frontotemporal Lobar Degeneration and Lewy Body Disease: Evidence for SORL1 as a Cross-Disease Gene
title_short Investigating the Endo-Lysosomal System in Major Neurocognitive Disorders Due to Alzheimer’s Disease, Frontotemporal Lobar Degeneration and Lewy Body Disease: Evidence for SORL1 as a Cross-Disease Gene
title_sort investigating the endo lysosomal system in major neurocognitive disorders due to alzheimer s disease frontotemporal lobar degeneration and lewy body disease evidence for sorl1 as a cross disease gene
topic SORL1
DNAJC6
PPT1
endo-lysosomal genes
NGS
cross-disease
url https://www.mdpi.com/1422-0067/22/24/13633
work_keys_str_mv AT luisabenussi investigatingtheendolysosomalsysteminmajorneurocognitivedisordersduetoalzheimersdiseasefrontotemporallobardegenerationandlewybodydiseaseevidenceforsorl1asacrossdiseasegene
AT antoniolongobardi investigatingtheendolysosomalsysteminmajorneurocognitivedisordersduetoalzheimersdiseasefrontotemporallobardegenerationandlewybodydiseaseevidenceforsorl1asacrossdiseasegene
AT cemilekocoglu investigatingtheendolysosomalsysteminmajorneurocognitivedisordersduetoalzheimersdiseasefrontotemporallobardegenerationandlewybodydiseaseevidenceforsorl1asacrossdiseasegene
AT matteocarrara investigatingtheendolysosomalsysteminmajorneurocognitivedisordersduetoalzheimersdiseasefrontotemporallobardegenerationandlewybodydiseaseevidenceforsorl1asacrossdiseasegene
AT soniabellini investigatingtheendolysosomalsysteminmajorneurocognitivedisordersduetoalzheimersdiseasefrontotemporallobardegenerationandlewybodydiseaseevidenceforsorl1asacrossdiseasegene
AT clarissaferrari investigatingtheendolysosomalsysteminmajorneurocognitivedisordersduetoalzheimersdiseasefrontotemporallobardegenerationandlewybodydiseaseevidenceforsorl1asacrossdiseasegene
AT rolandnicsanu investigatingtheendolysosomalsysteminmajorneurocognitivedisordersduetoalzheimersdiseasefrontotemporallobardegenerationandlewybodydiseaseevidenceforsorl1asacrossdiseasegene
AT claudiasaraceno investigatingtheendolysosomalsysteminmajorneurocognitivedisordersduetoalzheimersdiseasefrontotemporallobardegenerationandlewybodydiseaseevidenceforsorl1asacrossdiseasegene
AT cristianbonvicini investigatingtheendolysosomalsysteminmajorneurocognitivedisordersduetoalzheimersdiseasefrontotemporallobardegenerationandlewybodydiseaseevidenceforsorl1asacrossdiseasegene
AT silviafostinelli investigatingtheendolysosomalsysteminmajorneurocognitivedisordersduetoalzheimersdiseasefrontotemporallobardegenerationandlewybodydiseaseevidenceforsorl1asacrossdiseasegene
AT robertazanardini investigatingtheendolysosomalsysteminmajorneurocognitivedisordersduetoalzheimersdiseasefrontotemporallobardegenerationandlewybodydiseaseevidenceforsorl1asacrossdiseasegene
AT marcellacatania investigatingtheendolysosomalsysteminmajorneurocognitivedisordersduetoalzheimersdiseasefrontotemporallobardegenerationandlewybodydiseaseevidenceforsorl1asacrossdiseasegene
AT matthieumoisse investigatingtheendolysosomalsysteminmajorneurocognitivedisordersduetoalzheimersdiseasefrontotemporallobardegenerationandlewybodydiseaseevidenceforsorl1asacrossdiseasegene
AT philipvandamme investigatingtheendolysosomalsysteminmajorneurocognitivedisordersduetoalzheimersdiseasefrontotemporallobardegenerationandlewybodydiseaseevidenceforsorl1asacrossdiseasegene
AT giuseppedifede investigatingtheendolysosomalsysteminmajorneurocognitivedisordersduetoalzheimersdiseasefrontotemporallobardegenerationandlewybodydiseaseevidenceforsorl1asacrossdiseasegene
AT giulianobinetti investigatingtheendolysosomalsysteminmajorneurocognitivedisordersduetoalzheimersdiseasefrontotemporallobardegenerationandlewybodydiseaseevidenceforsorl1asacrossdiseasegene
AT christinevanbroeckhoven investigatingtheendolysosomalsysteminmajorneurocognitivedisordersduetoalzheimersdiseasefrontotemporallobardegenerationandlewybodydiseaseevidenceforsorl1asacrossdiseasegene
AT julievanderzee investigatingtheendolysosomalsysteminmajorneurocognitivedisordersduetoalzheimersdiseasefrontotemporallobardegenerationandlewybodydiseaseevidenceforsorl1asacrossdiseasegene
AT robertaghidoni investigatingtheendolysosomalsysteminmajorneurocognitivedisordersduetoalzheimersdiseasefrontotemporallobardegenerationandlewybodydiseaseevidenceforsorl1asacrossdiseasegene